These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
648 related articles for article (PubMed ID: 8560893)
1. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation. Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893 [TBL] [Abstract][Full Text] [Related]
2. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay. Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717 [TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease]. Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888 [TBL] [Abstract][Full Text] [Related]
4. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation]. Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863 [TBL] [Abstract][Full Text] [Related]
8. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients. Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905 [TBL] [Abstract][Full Text] [Related]
9. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients]. Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608 [TBL] [Abstract][Full Text] [Related]
10. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. Hebart H; Müller C; Löffler J; Jahn G; Einsele H Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710 [TBL] [Abstract][Full Text] [Related]
11. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients. Reynes J; Montes B; Atoui N; Segondy M J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964 [TBL] [Abstract][Full Text] [Related]
12. Role of antigenemia assay in the early diagnosis and treatment of CMV infection in renal transplant patients. Chiaramonte S; Pellizzer G; Rassu M; Dissegna D; Bragantiini L; Zuccarotto D; La Greca G Clin Nephrol; 2000 Apr; 53(4):suppl 10-2. PubMed ID: 10809428 [TBL] [Abstract][Full Text] [Related]
13. Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients. Vrtovec B; Thomas CD; Radovancevic R; Frazier OH; Radovancevic B J Heart Lung Transplant; 2004 Apr; 23(4):461-5. PubMed ID: 15063406 [TBL] [Abstract][Full Text] [Related]